This drug has boxed warnings. These are the most serious warnings from the Food and Drug Administration (FDA). A boxed warning alerts doctors and patients about drug effects that may be dangerous.

Adalimumab-adbm injection, a biosimilar to Humira ® (adalimumab), has been made available by Boehringer Ingelheim. Adalimumab-adbm injection is an interchangeable biosimilar and can be substituted for ...

Humira is a brand-name subcutaneous injection prescribed for certain conditions, such as rheumatoid arthritis. Humira’s price, with and without insurance, can depend on several factors, such as ...